发明名称 |
SUSTAINED-RELEASE LOCAL DRUG DELIVERY SYSTEM COMPRISING FIBRINOGEN, APROTININ, LIDOCAINE, EPINEPHRINE, AND COLLAGEN MEMBRANE, AND COMPOSITION FOR TREATING OSTEOPATHIA USING THE SAME |
摘要 |
<p>The present invention relates to a sustained-release local drug delivery system including fibrinogen, aprotinin, lidocaine, epinephrine, and collagen membrane, a kit, and a composition for treating osteopathia using the same. The sustained-release local drug delivery system according to the present invention can exhibit continuous pharmaceutically active effects with a small quantity by means of excellent sustained-release effects and excellently show biocompatibility including the promotion of revasculariation and new bone formation, so as to be usefully used as a sustained-release local drug delivery system for a pharmaceutically active material which needs to discharge drugs continuously for a long time and be usefully used to treat various diseases generated by incomplete osteogenesis by applying BMP to the local drug delivery system.</p> |
申请公布号 |
KR20140090481(A) |
申请公布日期 |
2014.07.17 |
申请号 |
KR20130002592 |
申请日期 |
2013.01.09 |
申请人 |
WONKWANG UNIVERSITY CENTER FOR INDUSTRY-ACADEMY COOPERATION |
发明人 |
KWON, KYUNG HWAN |
分类号 |
A61K9/08;A61K31/137;A61K31/167;A61K38/36 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|